Selank Peptide Research: GABAergic Signalling & Experimental Studies

Selank is a synthetic neuroactive peptide investigated in experimental research involving neurological signalling, stress-related biological pathways and neurochemical processes.

The peptide is structurally related to tuftsin and has been the subject of both preclinical and limited human research.

What Is Selank?

Selank is a synthetic heptapeptide with the amino-acid sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro.

It was developed from tuftsin, a naturally occurring peptide associated with immune-system signalling.

Researchers subsequently investigated Selank across neurological and neurochemical models, creating an unusual research profile spanning both nervous-system and immune-related signalling.

Selank and GABAergic Research

One of the most widely discussed areas of Selank research involves the GABAergic system.

Gamma-aminobutyric acid, or GABA, is an important inhibitory neurotransmitter within the central nervous system.

GABAergic signalling helps regulate neuronal activity through several receptor systems and forms an important part of neurological research.

Experimental studies have investigated how Selank may interact with pathways associated with GABA signalling.

The mechanisms involved remain an active area of investigation and should not be reduced to a simple claim that the peptide directly produces a particular psychological effect.

Selank and Stress-Related Research

Selank has also been investigated within experimental models involving physiological responses to stress.

Stress involves numerous interconnected biological systems, including neurotransmitter signalling, neuroendocrine responses and changes in gene expression.

Peptides provide researchers with one method of investigating these pathways and their interactions.

Selank and Gene Expression

Molecular research has examined whether exposure to Selank is associated with changes in gene expression.

Gene-expression studies can identify biological pathways that may respond to an experimental compound and provide clues about potential mechanisms.

However, changes in gene expression alone do not establish therapeutic efficacy.

Selank and Neuroimmune Research

Because Selank was developed from tuftsin, researchers have also investigated potential relationships between neurological and immune signalling.

The nervous and immune systems communicate through numerous molecular pathways, creating an expanding field often described as neuroimmunology.

This makes Selank scientifically interesting beyond its better-known association with neurological research.

Selank vs Semax

Selank and Semax are frequently discussed together, but they should not be considered versions of the same peptide.

Semax is derived from an ACTH fragment and has been investigated particularly in relation to neurotrophic pathways such as BDNF signalling.

Selank is derived from tuftsin and has a separate body of research involving GABAergic, stress and neuroimmune pathways.

Understanding this distinction is useful when reviewing the neuroactive peptide literature.

Explore Selank Research

Selank is included within the Kensington Labs Neuroactive Research Peptides collection alongside Semax, DSIP, PE-22-28, Pinealon, Cortagen and other research compounds.

Researchers can explore the Selank product page and our wider Neuroactive Research category for additional compound information and available analytical documentation.

All Kensington Labs peptides are supplied strictly for laboratory research purposes and are not intended for human consumption.